Company intelligence / Profile preview

Sleep Cycle

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Sleep Cycle has launched a clinical study to validate its upcoming smartphone-based feature for screening and monitoring obstructive sleep apnea using proprietary AI algorithms that analyze sound data from users’ smartphones. The solution aims to democratize access to early detection of OSA without requiring additional hardware or wearables. The company’s approach is evidence-based, with regulatory engagement including pre-submission dialogue with the U.S. FDA. Its core consumer app is already widely used globally for general sleep tracking and improvement[2][3][7].

Therapeutic areas: PulmonologyNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on Sleep Cycle.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sleep Cycle.

Explore the full profile